IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
2.013
-0.147 (-6.81%)
At close: Sep 9, 2025, 4:00 PM
2.070
+0.057 (2.83%)
After-hours: Sep 9, 2025, 6:17 PM EDT
IN8bio Market Cap
IN8bio has a market cap or net worth of $9.14 million as of September 9, 2025. Its market cap has decreased by -63.99% in one year.
Market Cap
9.14M
Enterprise Value
-801.58K
1-Year Change
-63.99%
Ranking
Category
Stock Price
$2.01
Market Cap Chart
Since the IPO on July 30, 2021, IN8bio's market cap has decreased from $187.55M to $9.14M, a decrease of -95.13%. That is a compound annual growth rate of -52.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 9.81M | -47.40% |
| Dec 31, 2024 | 18.64M | -68.76% |
| Dec 29, 2023 | 59.67M | 5.43% |
| Dec 30, 2022 | 56.60M | -31.25% |
| Dec 31, 2021 | 82.33M | -56.10% |
| Jul 30, 2021 | 187.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.84B |
| Johnson & Johnson | 429.72B |
| AbbVie | 375.50B |
| UnitedHealth Group | 285.64B |
| AstraZeneca | 253.68B |
| Novartis AG | 252.55B |
| Novo Nordisk | 244.67B |
| Abbott Laboratories | 231.38B |